CollPlant Biotechnologies Ltd is a leading regenerative medicine company focused on developing and commercializing plant-derived recombinant human collagen and collagen-based bioinks for tissue engineering, 3D bioprinting, and medical aesthetics. With a versatile product pipeline and strategic partnerships, CollPlant is poised for growth in the emerging field of regenerative medicine.